Name | Citric Acid Monohydrate + Potassium Citrate |
Classes |
Electrolyte and Mineral Nutritional Supplement |
Diseases |
Gout Kidney Disease Urinary Alkalinization |
Citric Acid Monohydrate + Potassium Citrate
Citric acid monohydrate + Potassium citrate is a systemic alkalizer that works by alkalinizing the urine and reducing the concentration of calcium salts, thus preventing the formation of kidney stones.
- This drug is indicated for the prevention of kidney stones and the treatment of certain metabolic disorders that cause an acidic urine.
- It is also used to reduce the acidity of urine in patients undergoing certain diagnostic procedures such as cystoscopy, urethroscopy, and bladder catheterization.
The dosage and administration of Citric acid monohydrate + Potassium citrate depends on the patient's age, medical condition, and response to treatment. Therefore, it is important to consult a healthcare provider before using this medication.
- The common adverse reactions of Citric acid monohydrate + Potassium citrate are nausea, vomiting, diarrhea, abdominal discomfort, and flatulence.
- Less common adverse reactions include hypokalemia, hyperkalemia, metabolic alkalosis, and muscle weakness.
- Rare adverse reactions include skin rash, allergic reaction, and irregular heartbeat.
- Citric acid monohydrate + Potassium citrate should not be used in patients with severe renal impairment or in those with hyperkalemia.
- It should be used with caution in patients with a history of heart disease, high blood pressure, or liver disease.
- Patients taking this medication should have their serum potassium levels monitored regularly to avoid hyperkalemia.
- Patients with a history of kidney stones should increase their fluid intake to maintain a urine output of at least 2 liters per day.
- This medication may interact with certain medications, including potassium-sparing diuretics, nonsteroidal anti-inflammatory drugs (NSAIDs), and ACE inhibitors, among others.
Contraindication
Contraindicated in patients hypersensitive to any component of the formulation.
None known.
Citric acid monohydrate + Potassium citrate is contraindicated in patients with hyperkalemia, severe renal impairment, and Addison's disease.